How M.D. was paid
$2.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Steven D. Harr, M.D.President, Chief Executive Officer, and Director | $696,140 | $425,001 | $1,327,500 | $450,369 | $4,000 | $2,903,010 |
| Bernard J. CassidyFormer Executive Vice President, General Counsel, and Corporate Secretary | $404,034 | $135,999 | $424,800 | — | $51,280 | $1,016,113 |
What changed and why
- $2.9MSteven D. Harr received a total compensation of $2,903,010 in fiscal 2025, down from $8,788,580 in 2024.
- 107.5%Corporate goals for 2025 were achieved at 107.5% based on progress in clinical and manufacturing programs.
- $450KSteven D. Harr's annual bonus for 2025 was approved at $450,369 reflecting goal achievement.
- $51,280Bernard J. Cassidy resigned effectively on October 19, 2025, and received $51,280 in all other compensation including accrued PTO.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.